MedImmune
id:
medimmune-310-15071895
title:
MedImmune
text:
MedImmune, LLC was a wholly owned subsidiary of AstraZeneca before February 14, 2019, when it was announced that the MedImmune name and branding would be discontinued in favor of AstraZeneca. MedImmune was founded in 1988 as Molecular Vaccines, Inc, and was purchased in 2007 for $15.6 billion. Its main offices were located in Gaithersburg, MD, Cambridge, UK, and Mountain View, CA. It produced Synagis, a drug for the prevention of respiratory infections in infants, which accounted for US$ 1.06 bi
brand slug:
wiki
category slug:
encyclopedia
description:
Biopharmaceutical company, acquired by AstraZeneca in 2007
original url:
https://en.wikipedia.org/wiki/MedImmune
date created:
date modified:
2023-10-28T00:48:25Z
main entity:
{"identifier":"Q1335294","url":"https://www.wikidata.org/entity/Q1335294"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/c0/MedImmune_logo.gif","width":300,"height":120}
fields total:
13
integrity:
15